Searched for
SME DRUG
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...- Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listingBio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Bio Medica Laboratories IPO: Check GMP, price band, subscription and other detailsBio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- IPO Calendar: 8 IPOs, 11 listings investors need to watch out for next weekAnalysts said India's capital markets are playing a vital role in the country's growth, thanks to advancements in technology, innovation, a...
- Quest Laboratories IPO opens today: Check issue size, price band, GMP and other detailsQuest Laboratories SME IPO opens today to raise Rs 43 crore through a fresh equity issue of 44.49 lakh shares at Rs 93-97 apiece on NSE SME...
- Zenith Drugs IPO: Check issue size, price band, GMP and other detailsThe net proceeds from the public offer will be used for the purchase of machinery and setting up the new plant, existing manufacturing bloc...
- This SME stock plunges 9% after promoter offloads 8.5% stake in open marketEVOQ Remedies' promoter Payal Bhumishth Patel sold 11,52,000 shares, representing an 8.5% stake on January 10, according to exchange disclo...
- Valiant Organics lists on BSE SME platform, total hits 155Valiant Organics came out with an initial public offering (IPO) of 9,64,800 shares of face value of Rs 10 each at a fixed price of Rs 220 p...
- Mutual Funds start investing in SME IPOsMFs have begun investing in quality SME IPO, with a public issue of over Rs 21 crore by Valiant Organics getting investment from Reliance M...
- Government looking into SME drug firms' request on barcodingGovernment is considering the request from the small and medium sized pharma firms regarding the difficulties faced by them on barcoding on...
- Drug companies may be told to upgrade facilities to meet PICS standardsIndia is looking at persuading thousands of drug makers to upgrade their manufacturing facilities to help the country meet PICS standards.
- After price cuts, big pharma companies focussing on brands, distributionBig pharmaceutical companies’ profit margins may be under pressure because of a government-induced fall in prices of dozens of medicines, b...
- Small drug cos on anti-buyout driveConcerned about the recent spate of takeovers of domestic pharma firms by MNCs, small and medium players in the sector have decided to appr...
- Small drug firms to seek protectionConcerned about the recent spate of takeovers of domestic pharma firms by MNCs, small and medium players in the sector have decided to appr...
- Cos find 'new' combo drug quite oldThe pharma industry has opposed the drug controller general of India (DCGI) decision to include diclofenac-paracetamol combination-a non-st...
- Pharma ministry asks NPPA to clear price change applications in 30 daysThe department of pharmaceuticals has asked the National Pharmaceutical Pricing Authority (NPPA) to clear price revision applications recei...
- Higher prices for 70 drugsThe government may agree to price increases in 70 scheduled drugs and revise those of several bulk drugs.
- SME pharmas likely to get interest sopsThe government may provide an interest subsidy to small and medium-size pharma companies to upgrade their facilities in order to meet strin...
Load More
